Cell Reports · 2022 · 30 citations · 65 references
Life SciencesMolecular BiologyOncologyApoptosisDna ReplicationMolecular OncologyDna Damage SignalingDna Damage-induced ApoptosisDna Polymerase FunctionReplication Fork ProgressionReplication InitiationReplication TerminationDna Damage-induced Cell DeathFork Restart MechanismsParp InhibitionPoly(adp-ribose) Polymerase 1Poly(adp-ribose) Polymerase InhibitionReplication Fork ReversalReplication Fork StabilizationTumor Suppressor P53
The MDM2 oncoprotein antagonizes the tumor suppressor p53 by physical interaction and ubiquitination. However, it also sustains the progression of DNA replication forks, even in the absence of functional p53. Here, we show that MDM2 binds, inhibits, ubiquitinates, and destabilizes poly(ADP-ribose) polymerase 1 (PARP1). When cellular MDM2 levels are increased, this leads to accelerated progression of DNA replication forks, much like pharmacological inhibition of PARP1. Conversely, overexpressed PARP1 restores normal fork progression despite elevated MDM2. Strikingly, MDM2 profoundly reduces the frequency of fork reversal, revealed as four-way junctions through electron microscopy. Depletion of RECQ1 or the primase/polymerase (PRIMPOL) reverses the MDM2-mediated acceleration of the nascent DNA elongation rate. MDM2 also increases the occurrence of micronuclei, and it exacerbates camptothecin-induced cell death. In conclusion, high MDM2 levels phenocopy PARP inhibition in modulation of fork restart, representing a potential vulnerability of cancer cells.
65
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves et al. · Science · 2004 · 4.7K citations
Medicine, Oncology, Pharmacology +15
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Jonathan D. Oliner, Jennifer A. Pietenpol, Sam Thiagalingam et al. · Nature · 1993 · 1.5K citations
Medicine, Cancer Biology, Oncology +16